Randomized Trialhigh evidence
Vasopressin-Based Versus Norepinephrine-Based Strategy in Vasoplegic Syndrome After Cardiac Surgery: A Randomized Controlled Trial.
Journal of intensive care medicine·July 29, 2026·PMID 42524721
Why it mattersVasoplegic syndrome after cardiopulmonary bypass is common and challenging to manage. A vasopressin-first approach may offer hemodynamic advantages and reduce length of stay compared to norepinephrine, providing an evidence-based alternative for early vasopressor selection in postoperative cardiac surgical patients.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled